Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Biomarkers Assist in Detecting Life-Threatening Kidney Injury after Cardiac Surgery

Published: Friday, March 02, 2012
Last Updated: Friday, March 02, 2012
Bookmark and Share
The findings suggest that early detection and better patient monitoring could prevent kidney deterioration.

Following heart surgery, patients commonly experience acute kidney injury (AKI) and a progressive loss of kidney function. But a Yale-led study identifies specific blood and urine markers that can predict which patients will suffer these serious complications.  The study appears online in the Journal of the American Society of Nephrology.

Acute kidney injury is a frequent complication of cardiac surgery that may lead to several adverse outcomes, including higher patient mortality. Previous studies have shown that several biomarkers can forecast early-onset AKI after cardiac surgery. However, most episodes of AKI are transient and will last only for a few days. Just 10 to 15 percent of patients will progress to severe AKI. Until now, there have been no effective tools to predict the risk of progressively worsening kidney function at the time of early-onset AKI.

The Yale-led research team, along with researchers from other institutions in the United States and Canada, are known as the Translational Research Investigating Biomarker End-Points in AKI consortium (TRIBE-AKI), a multidisciplinary group of academic investigators with expertise in pre-clinical, translational, epidemiologic and health services research.

The TRIBE-AKI consortium evaluated blood and urine samples of 380 cardiac surgery patients on the day they were diagnosed with AKI, and found that one blood and two urine biomarkers (blood neutrophil gelatinase-associated lipocalin, urine IL-18, and urine albumin/creatinine ratio) forecast the future progressive deterioration in kidney injury as well as adverse patient outcomes.

“Daily monitoring of these biomarkers after cardiac surgery can provide us with an earlier window to intervene in cases where patients will have continued deterioration of their kidney function after surgery,” said lead author and principal investigator Chirag Parikh, M.D. Ph.D., director of the Program of Applied Translational Research and associate professor of nephrology at Yale School of Medicine and the Veterans Affairs Medical Center.

Other authors are Jay L. Koyner of the University of Chicago, Amit X. Garg and Heather Thiessen-Philbrook of the University of Western Ontario, Steven G. Coca and Kyaw Sint of Yale, Uptal D. Patel of Duke, and Michael G. Shilpak of the University of California San Francisco for the TRIBE-AKI Consortium.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
New Biomarker to Assess Stem Cells Developed
A research team led by scientists from UCL have found a way to assess the viability of 'manufactured' stem cells known as induced pluripotent stem cells (iPSCs). The team's discovery offers a new way to fast-track screening methods used in stem cell research.
A Better Model for Parkinson's
Scientists at EPFL solve a longstanding problem with modeling Parkinson’s disease in animals. Using newfound insights, they improve both cell and animal models for the disease, which can propel research and drug development.
Faster Drug Discovery?
Startup develops more cost-effective test for assessing how cells respond to chemicals.
Microalgae Make a Splash in the UK Cosmeceutical Market
Scottish innovators have discovered an anti-viral and anti-inflammatory carbohydrate in microscopic algae (microalgae) which has huge potential to change the cosmetics market.
Mechanism of Tumor Suppressing Gene Uncovered
The most commonly mutated gene in cancer,p53, works to prevent tumor formation by keeping mobile elements in check that otherwise lead to genomic instability, UT Southwestern Medical Center researchers have found.
Experimental Combination Surprises with Anti-HIV Effectiveness
A compound developed to protect the nervous system from HIV surprised researchers by augmenting the effectiveness of an investigational antiretroviral drug beyond anything expected.
Useful Colon Cancer Biomarker Discovered
Biomarker is detectable with simple, inexpensive test.
A New Type of Anticancer Agent
Success in the development of a ?-tubulin specific inhibitor.
Seeing Hope
Gene therapy/drug combo restores some vision in mice with optic nerve injury.
Versatile New Molecule-Building Technique
Chemists at The Scripps Research Institute (TSRI) have devised a new and widely applicable technique for building potential drug molecules and other organic compounds.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!